Valencia, CA, United States of America

Abirami Muralidharan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abirami Muralidharan: Innovator in Dry Eye Treatment Technology

Introduction

Abirami Muralidharan is a notable inventor based in Valencia, CA (US). She has made significant contributions to the field of ophthalmology, particularly in the area of dry eye treatment. Her innovative approach combines technology and healthcare to improve patient outcomes.

Latest Patents

Muralidharan holds a patent for an "Apparatus and method for dry eye forecast and treatment recommendation." This invention involves a machine that includes a processor and a memory connected to the processor. The memory stores instructions executed by the processor to determine first and second properties related to dry eye symptoms of a patient. These properties are utilized to form a dry eye forecast, and a treatment recommendation is selected based on this forecast. The treatment recommendation can then be supplied to a device, enhancing the management of dry eye conditions.

Career Highlights

Abirami Muralidharan has been instrumental in her role at Oculeve, Inc., where she has contributed to the development of innovative solutions for eye care. Her work has garnered attention for its potential to transform how dry eye symptoms are forecasted and treated.

Collaborations

Muralidharan collaborates with talented professionals in her field, including Manfred Franke and Chao Liu. These partnerships enhance the research and development efforts at Oculeve, Inc., fostering an environment of innovation.

Conclusion

Abirami Muralidharan's contributions to the field of dry eye treatment exemplify the impact of innovation in healthcare technology. Her patent and work at Oculeve, Inc. highlight her commitment to improving patient care through advanced solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…